Adipose Tissue Expansion by Overfeeding Healthy Men Alters Iron Gene Expression.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 03 2019
Historique:
received: 01 06 2018
accepted: 20 09 2018
pubmed: 28 9 2018
medline: 18 12 2019
entrez: 28 9 2018
Statut: ppublish

Résumé

Iron overload has been associated with greater adipose tissue (AT) depots. We retrospectively studied the potential interactions between iron and AT during an experimental overfeeding in participants without obesity. Twenty-six participants (mean body mass index ± SD, 24.7 ± 3.1 kg/m2) underwent a 56-day overfeeding (+760 kcal/d). Serum iron biomarkers (ELISA), subcutaneous AT (SAT) gene expression, and abdominal AT distribution assessed by MRI were analyzed at the beginning and the end of the intervention. Before intervention: SAT mRNA expression of the iron transporter transferrin (Tf) was positively correlated with the expression of genes related to lipogenesis (lipin 1, ACSL1) and lipid storage (SCD). SAT expression of the ferritin light chain (FTL) gene, encoding ferritin (FT), an intracellular iron storage protein, was negatively correlated to SREBF1, a gene related to lipogenesis. Serum FT (mean, 92 ± 57 ng/mL) was negatively correlated with the expression of SAT genes linked to lipid storage (SCD, DGAT2) and to lipogenesis (SREBF1, ACSL1). After intervention: Overfeeding led to a 2.3 ± 1.3-kg weight gain. In parallel to increased expression of lipid storage-related genes (mitoNEET, SCD, DGAT2, SREBF1), SAT Tf, SLC40A1 (encoding ferroportin 1, a membrane iron export channel) and hephaestin mRNA levels increased, whereas SAT FTL mRNA decreased, suggesting increased AT iron requirement. Serum FT decreased to 67 ± 43 ng/mL. However, no significant associations between serum iron biomarkers and AT distribution or expansion were observed. In healthy men, iron metabolism gene expression in SAT is associated with lipid storage and lipogenesis genes expression and is modulated during a 56-day overfeeding diet.

Identifiants

pubmed: 30260393
pii: 5106937
doi: 10.1210/jc.2018-01169
doi:

Substances chimiques

Biomarkers 0
Cation Transport Proteins 0
FTL protein, human 0
HEPH protein, human 0
Membrane Proteins 0
SREBF1 protein, human 0
Sterol Regulatory Element Binding Protein 1 0
metal transporting protein 1 0
Apoferritins 9013-31-4
Iron E1UOL152H7

Banques de données

ClinicalTrials.gov
['NCT00905892']

Types de publication

Clinical Trial Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

688-696

Auteurs

Berenice Segrestin (B)

Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France.
Eating Disorder Unit, Groupe Hospitalier Est, Hospices Civils de Lyon, Bron, France.

José Maria Moreno-Navarrete (JM)

Department of Diabetes, Endocrinology and Nutrition, Girona Biomedical Research Institute, Hospital Universitari de Girona Dr Josep Trueta, Departament de Medicina, Universitat de Girona, CIBER Fisiopatologia de la Obesidad y Nutricion, Girona, Spain.

Kevin Seyssel (K)

Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France.

Maud Alligier (M)

Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France.
F-CRIN/FORCE Network, Pierre Bénite, France.

Emmanuelle Meugnier (E)

Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France.

Julie-Anne Nazare (JA)

Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France.

Hubert Vidal (H)

Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France.

José Manuel Fernandez-Real (JM)

Department of Diabetes, Endocrinology and Nutrition, Girona Biomedical Research Institute, Hospital Universitari de Girona Dr Josep Trueta, Departament de Medicina, Universitat de Girona, CIBER Fisiopatologia de la Obesidad y Nutricion, Girona, Spain.

Martine Laville (M)

Univ-Lyon, CarMeN Laboratory, and Centre de Recherche en Nutrition Humaine Rhône-Alpes, Université Claude Bernard Lyon1, Pierre Benite, France.
Endocrinology, Diabetes, and Nutrition Department, Groupe Hospitalier Sud, Hospices Civils de Lyon, Pierre Benite, France.
F-CRIN/FORCE Network, Pierre Bénite, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH